Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Researchers need your help. By taking part in research studies and clinical trials, you will help them make progress to improve lives and find a cure for type 1 diabetes.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Your donation helps support people living with type 1 diabetes and funds the best treatment and cure research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > News & events > News > Type 1 diabetes diagnoses unaffected by reported lab test errors
The issue affects both type 1 and type 2 diabetes, as the HbA1c test is used in monitoring both conditions. However, HbA1c is not used in the same way to diagnose type 1 diabetes, so the impact on T1D diagnoses is expected to be far less. People with type 1 diabetes also have continuous glucose monitoring (CGM) data to support and guide their care, further reducing any potential impact.
In contrast, HbA1c is a central tool for type 2 diabetes diagnosis and management, which is why recent reports have focused on that group.
The National Diabetes Audit shows no increase in type 1 diagnoses during the period when the calibration issue occurred (April – December 2024), and none of the 16 hospital laboratories involved have reported any impact on type 1 testing.
If you live with type 1 diabetes, this means your diagnosis and ongoing care should not have been affected by the issues raised in recent reports. As always, if you have individual concerns about your test results or diabetes care, we encourage you to speak directly with your healthcare team.
We remain in close contact with NHS England and regulators to ensure people with type 1 diabetes continue to receive safe, accurate testing and care.
Learn more about insulin pumps, continuous glucose monitors, smart insulin pens and hybrid closed loop systems.
Find out about our work to make T1D treatments available to everyone who needs or wants them.
Find out about our research to find cures for T1D and make everyday life better for those who face it.
You may have heard of a new feature called ‘CamAPS Liberty’, which will soon be available on the CamAPS FX app. This ‘fully closed-loop’ (FCL) mode, when activated; will allow users to remove the need to count carbohydrates before a meal. But what does this mean for people with type 1 diabetes (T1D), and how close are we to removing meal announcement altogether? Here is what we know…
In draft guidance published today, NICE recommends that anyone with type 1 diabetes who is pregnant or planning a pregnancy should be offered pregnancy-specific HCL technology.
Discussing the main themes from this year's Advanced Technologies & Treatments for Diabetes conference – early detection, cellular cures and disease-modifying therapies.
Highlights from an extraordinary year in type 1 diabetes (T1D) research, treatment, advocacy and policy.
Immunotherapy, beta cell replacement, smart insulins – we’re driving research in the most promising areas to find cures and better treatments for type 1 diabetes.
